539206 — Genomic Valley Biotech Balance Sheet
0.000.00%
- IN₹144.17m
- IN₹143.72m
- IN₹8.44m
Annual balance sheet for Genomic Valley Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.115 | 0.027 | 0.413 | 0.061 | 0.452 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.649 | 0 | 22.2 | 25.3 | 22.1 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 1.64 | 11.4 | 25.8 | 29.1 | 26.2 |
Net Property, Plant And Equipment | 63.3 | 17.5 | 0.032 | 0.021 | 0.087 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 76.2 | 38 | 44.2 | 43.3 | 43.6 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 8.71 | 2.14 | 8.93 | 7.91 | 4.58 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 31.3 | 9.19 | 8.94 | 7.92 | 4.58 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 44.9 | 28.8 | 35.3 | 35.4 | 39 |
Total Liabilities & Shareholders' Equity | 76.2 | 38 | 44.2 | 43.3 | 43.6 |
Total Common Shares Outstanding |